DK1856125T3 - Syntese af proteasehæmmerforstadie - Google Patents

Syntese af proteasehæmmerforstadie

Info

Publication number
DK1856125T3
DK1856125T3 DK06724879T DK06724879T DK1856125T3 DK 1856125 T3 DK1856125 T3 DK 1856125T3 DK 06724879 T DK06724879 T DK 06724879T DK 06724879 T DK06724879 T DK 06724879T DK 1856125 T3 DK1856125 T3 DK 1856125T3
Authority
DK
Denmark
Prior art keywords
synthesis
protease inhibitor
inhibitor precursor
precursor
processes
Prior art date
Application number
DK06724879T
Other languages
Danish (da)
English (en)
Inventor
Bruno Linclau
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Application granted granted Critical
Publication of DK1856125T3 publication Critical patent/DK1856125T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK06724879T 2005-02-25 2006-02-24 Syntese af proteasehæmmerforstadie DK1856125T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05101462 2005-02-25
US68369905P 2005-05-23 2005-05-23
PCT/EP2006/060246 WO2006089942A1 (en) 2005-02-25 2006-02-24 Protease inhibitor precursor synthesis

Publications (1)

Publication Number Publication Date
DK1856125T3 true DK1856125T3 (da) 2009-12-07

Family

ID=36646227

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06724879T DK1856125T3 (da) 2005-02-25 2006-02-24 Syntese af proteasehæmmerforstadie

Country Status (19)

Country Link
US (2) US8067463B2 (he)
EP (1) EP1856125B1 (he)
JP (1) JP5260965B2 (he)
KR (1) KR101333627B1 (he)
CN (1) CN101128469B (he)
AT (1) ATE440848T1 (he)
AU (1) AU2006217922B2 (he)
BR (1) BRPI0607827B8 (he)
CA (1) CA2595295C (he)
DE (1) DE602006008751D1 (he)
DK (1) DK1856125T3 (he)
ES (1) ES2331257T3 (he)
IL (1) IL184519A (he)
MX (1) MX2007010378A (he)
NO (1) NO20074880L (he)
PL (1) PL1856125T3 (he)
PT (1) PT1856125E (he)
RU (1) RU2421459C2 (he)
WO (1) WO2006089942A1 (he)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5288153B2 (ja) * 2007-03-30 2013-09-11 日油株式会社 糖アルコール誘導体およびアルケニル基含有糖アルコール誘導体の製造方法
WO2012075122A2 (en) * 2010-11-30 2012-06-07 Purdue Research Foundation Processes and intermediates for preparing substituted hexahydrofuro [2,3-b] furans

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1088098T4 (en) 1998-06-23 2015-09-14 Us Of America Represented By The Secretary Dept Of Health And Human Services Fitnessassay and methods for reducing HIV resistance to therapy
WO1999067254A2 (en) 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof
EP1089328A1 (en) * 1999-09-29 2001-04-04 Infineon Technologies AG Method for manufacturing of a semiconductor device
EP1222192B8 (en) 1999-10-06 2008-10-01 Tibotec Pharmaceuticals Ltd. Hexahydrofuro¬2,3-b furan-3-yl-n- 3-¬(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino -1-benzyl-2-hydroxypropyl carbamate as retroviral protease inhibitor
CZ304273B6 (cs) 2001-02-14 2014-02-12 Tibotec Pharmaceuticals Ltd. 2-(Substitovaná-amino)benzothiazolsulfonamidová sloučenina, způsob její přípravy a farmaceutická kompozice s jejím obsahem
OA12464A (en) 2001-04-09 2006-05-24 Tibotec Pharm Ltd Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors.
US7622490B2 (en) 2001-05-11 2009-11-24 Tibotec Pharmaceuticals, Ltd. Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitors
US7087373B2 (en) 2001-06-05 2006-08-08 Tibotec Pharmaceuticals Ltd. Methods for determining plasma free drug concentration by direct measurement of binding affinity of protease inhibitors to plasma proteins
TWI286476B (en) 2001-12-12 2007-09-11 Tibotec Pharm Ltd Combination of cytochrome P450 dependent protease inhibitors
EA009556B1 (ru) 2001-12-21 2008-02-28 Тиботек Фармасьютикалз Лтд. Гетероциклические замещённые фенилсодержащие сульфонамиды широкого спектра действия в качестве ингибиторов протеазы вич
US7109230B2 (en) 2002-01-07 2006-09-19 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
AU2003208751A1 (en) 2002-02-22 2003-09-09 Tibotec Bvba Methods for determining the influence of protein binding on antiretroviral activity
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
US7157489B2 (en) 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
US7462608B2 (en) 2002-04-26 2008-12-09 Gilead Sciences, Inc. Non nucleoside reverse transcriptase inhibitors
US7700645B2 (en) 2002-05-16 2010-04-20 Tibotec Pharmaceuticals Ltd. Pseudopolymorphic forms of a HIV protease inhibitor
MXPA04011466A (es) 2002-05-17 2005-02-14 Tibotec Pharm Ltd Inhibidores de la proteasa de hiv de benzisoxazol sulfonamida sustituida de amplio espectro.
EP1520247B1 (en) 2002-07-01 2009-05-27 Tibotec Pharmaceuticals Ltd. Mutational profiles in hiv-1 protease correlated with phenotypic drug resistance

Also Published As

Publication number Publication date
KR20080005183A (ko) 2008-01-10
ATE440848T1 (de) 2009-09-15
CA2595295A1 (en) 2006-08-31
AU2006217922A1 (en) 2006-08-31
US8183394B2 (en) 2012-05-22
EP1856125B1 (en) 2009-08-26
JP5260965B2 (ja) 2013-08-14
AU2006217922B2 (en) 2012-04-05
DE602006008751D1 (de) 2009-10-08
MX2007010378A (es) 2007-09-25
PT1856125E (pt) 2009-11-06
US8067463B2 (en) 2011-11-29
WO2006089942A8 (en) 2007-12-13
WO2006089942A1 (en) 2006-08-31
US20120041215A1 (en) 2012-02-16
CN101128469A (zh) 2008-02-20
PL1856125T3 (pl) 2010-01-29
RU2007135345A (ru) 2009-03-27
IL184519A0 (en) 2007-10-31
US20090054668A1 (en) 2009-02-26
NO20074880L (no) 2007-09-25
RU2421459C2 (ru) 2011-06-20
BRPI0607827A2 (pt) 2009-10-06
EP1856125A1 (en) 2007-11-21
KR101333627B1 (ko) 2013-11-27
BRPI0607827B8 (pt) 2021-05-25
CN101128469B (zh) 2012-11-14
IL184519A (he) 2012-01-31
JP2008531522A (ja) 2008-08-14
ES2331257T3 (es) 2009-12-28
BRPI0607827B1 (pt) 2019-11-05
CA2595295C (en) 2014-07-08

Similar Documents

Publication Publication Date Title
CR7680A (es) Un nuevo proceso para la sintesis de agomelatina
CY1112467T1 (el) Παραγωγα 1-θειο-d-γλυκιτολης
BRPI0615029A2 (pt) processos e intermediários
EA200500201A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
BRPI0615705A2 (pt) processo para preparar um composto, e, composto
MX2007003118A (es) Procedimiento de intermediarios para preparar inhibidores de cisteina proteasa.
BRPI0710199A2 (pt) Processo para preparação de inibidores de hiv protease
EA200500202A1 (ru) Новый способ синтеза (7-метокси-3,4-дигидро-1-нафталинил)ацетонитрила и его применение при синтезе агомелатина
MX2007014172A (es) Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
CY1110010T1 (el) Πυριδιναμινοσουλφονυλ υποκατεστημενα βενζαμιδια ως αναστολεις κυτοχρωματος ρ450 3α4 (cyp3a4)
TW200640914A (en) Novel processes for the preparation of a benzofuran
ITMI20050801A1 (it) Procedimento per la preparazione di telmisartan
AR054533A1 (es) Proceso y reactivo magnetico para la separacion de impurezas de los minerales
UA97806C2 (ru) Бензиламины, способ их получения и их применения в качестве противовоспалительных средств
EA201000257A1 (ru) Новый способ синтеза (7-метокси-l-нафтил) ацетонитрила и применение в синтезе агомелатина
EA200500204A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
IL189286A0 (en) Novel cysteine protease inhibitors and their therapeutic applications
NI200700175A (es) Procesos para la preparación de alcoholes de aminoetoxibencilo
DK1856125T3 (da) Syntese af proteasehæmmerforstadie
NO20083730L (no) Fremgangsmate for fremstilling av entakapon
TW200728267A (en) Processes and intermediates for the preparation of prostaglandins
UA94391C2 (ru) Синтез предшественника ингибитора протеазы
EA200802065A1 (ru) Синтез замещённых флуоренов
CY1115133T1 (el) Μεθοδος παρασκευης αναστολεων hiv πρωτεασης
CY1113913T1 (el) Αναστολεις ρενινης